AARON MATTHEW DOMMU
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology TRUMBULL, CT NPI 1548437148
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology CT Ardelyx, Inc. All categories
General Payments — all program years on this page
$1,550.57
- Category: General Payments
- Program years: PY2018–2024
- Record count: 72
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $181.78 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $179.40 | 8 |
| Education | $2.38 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Ardelyx, Inc. | $53.23 | 3 |
| Acerta Pharma LLC | $48.50 | 2 |
| Lilly USA, LLC | $28.25 | 1 |
| Retrophin, Inc. | $27.59 | 2 |
| Aurinia Pharma U.S., Inc. | $24.21 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104451978 | AstraZeneca Pharmaceuticals LP | $24.23 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104643599 | AstraZeneca Pharmaceuticals LP | $24.27 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135994386 | Lilly USA, LLC | $28.25 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146678587 | Ardelyx, Inc. | $17.90 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146678589 | Ardelyx, Inc. | $19.13 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146678591 | Ardelyx, Inc. | $16.20 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149885999 | Travere Therapeutics, Inc. | $2.38 | 06/07/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149886003 | Travere Therapeutics, Inc. | $25.21 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150679303 | Aurinia Pharma U.S., Inc. | $24.21 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.